Procurement Summary
Country : Brazil
Summary : Price Registration for Future Medicines Acquisition - Manipulated 2. Protocol No. 21.915.494-1
Deadline : 15 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 121901712
Document Ref. No. : 90840/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Price Registration for Future Medicines Acquisition - Manipulated 2. Protocol No. 21.915.494-1
UASG Code: 456793
Notice from: 01/07/2025 from 08:00 to 12:00 and from 13:00 to 17:59 hs
Proposal Delivery: From 01/07/2025 to 08:00
ERYTHROMYCIN, Stoolato presentation, concentration 50 mg/ml, use oral suspension
Quantity: 352
Sildenafil, composition salt citrate, concentration 2.5 mg/ml, pharmaceutical form oral solution, additional characteristic formulation especially manipulated
Quantity: 622
Folinic acid, 5 mg/ml concentration, form Pharmaceutical oral solution, additional specially manipulated
Quantity: 384
Nifedipine, concentration 1 mg/ml, pharmaceutical form oral solution, additional characteristic special formulation
Quantity: 52
Nifedipine, concentration 1 mg/ml, pharmaceutical form oral solution, characteristic Additional formulation specially manipulated
Quantity: 52
Activated charcoal, pharmaceutical form powder, additional characteristics especially manipulated formulation
Quantity: 206
Potassium hydroxide, 10%concentration, pharmaceutical form aqueous solution, additional formulation especially Manipulated
Quantity: 212
Omeprazole, concentration 2 mg/ml, pharmaceutical form oral suspension, additional characteristic special formulation
Quantity: 3926
Neomicin, 500mg concentration, additional characteristic medication specially manipulated
Sulfadiazine, Concentration 150 mg/ml, pharmaceutical form oral solution, additional characteristic* especially manipulated formulation
Quantity: 292
Pyrimetamine, concentration 2 mg/ml, pharmaceutical form oral suspension, additional characteristic formulation specially manipulated
Papain, concentration 10%, pharmaceutical form cream, additional characteristic formulation specially manipulated ...
Documents
Tender Notice